Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer and hormonal replacement therapy.

Rena Vassilopoulou-Sellin1

  • 1Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. rsellin@mail.mdanderson.org

Annals of the New York Academy of Sciences
|December 3, 2003
PubMed
Summary

Hormone replacement therapy (HRT) use may increase breast cancer diagnosis but appears linked to more favorable outcomes and reduced mortality. Evidence does not strongly support HRT worsening recurrence in breast cancer survivors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape.

The Journal of clinical endocrinology and metabolism·2020
Same author

Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.

Endocrine·2015
Same author

Visual vignette.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2014
Same author

Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndrome.

Surgery·2014
Same author

Mitotane-induced hyperlipidemia: a retrospective cohort study.

International journal of endocrinology·2013
Same author

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.

European journal of endocrinology·2013

Area of Science:

  • Oncology
  • Endocrinology
  • Women's Health

Background:

  • The relationship between hormone replacement therapy (HRT) and breast cancer diagnosis and outcomes remains a complex issue.
  • While prolonged HRT use is associated with increased breast cancer diagnoses, a definitive causal link is uncertain.
  • Existing clinical impressions suggest HRT may not adversely affect breast cancer outcomes.

Purpose of the Study:

  • To investigate the association between HRT, breast cancer diagnosis, and clinical outcomes in women.
  • To evaluate the impact of HRT on breast cancer recurrence and survival.
  • To inform clinical decisions regarding HRT use by weighing benefits against potential risks.

Main Methods:

  • Review of existing literature on HRT and breast cancer.

Related Experiment Videos

  • Analysis of clinical data regarding tumor characteristics and survival in HRT users.
  • Assessment of retrospective studies on HRT and breast cancer recurrence.

    • Main Results:

    • Women using HRT who develop breast cancer tend to have more localized tumors with favorable histology.
    • Overall death rates from breast cancer appear reduced in HRT users.
    • Limited evidence suggests HRT does not adversely affect breast cancer recurrence, despite contraindication concerns.

    Conclusions:

    • The clinical outcome for breast cancer patients using HRT appears favorable, with localized disease and reduced mortality.
    • The contraindication of HRT in breast cancer survivors is based on limited evidence; studies do not show adverse effects on recurrence.
    • Individualized assessment of HRT benefits (symptom relief) versus risks (breast cancer) is crucial for patient care.